Inhaled Agents for COPD and Asthma

    Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis

    Tricco AC, Strifler L, Veroniki AA, Yazdi F, Khan PA, Scott A, Ng C, Antony J, Mrklas K, D'Souza J, Cardoso R, Straus SE. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open. 2015;5(10):e009183. DOI: 10.1136/bmjopen-2015-009183.

    Altmetric:

    Impact:

    • Considered by Ontario Public Drug Program to inform the listing of these agents
    Funding:

    Ontario Drug Policy Research Network (ODPRN), Ontario Ministry of Health and Long-Term Care (OMHLTC)


    Comparative Safety and effectiveness of long-acting muscarinic antagonists for chronic obstructive pulmonary disease (COPD): A rapid review and network meta-analysis

    Tricco AC, Strifler L, Yazdi F, Khan P, Ng C, Antony J, Mrklas K, Scott A, D’Souza J, Cardoso R. Comparative safety and effectiveness of long-acting muscarinic antagonists for chronic obstructive pulmonary disease (COPD): A rapid review and network meta-analysis. Technical Report 2014.

    Impact:

    • Considered by Ontario Public Drug Program to inform the listing of these agents

    Protocol:

    Additional Resources:

    Funding:

    Ontario Drug Policy Research Network (ODPRN), Ontario Ministry of Health and Long-Term Care (OMHLTC)


    Comparative safety and effectiveness of inhaled corticosteriods and beta-agonist for chronic asthma: A rapid review and network meta-analysis

    Tricco AC, Ashoor HM, Zarin W, Thomas S, Hamid J, Yazdi F, Lillie E, Kealey R, Ghassemi M, Loyman RJ. Comparative safety and effectiveness of inhaled corticosteroids and beta-agonists for chronic asthma: A rapid review and network meta-analysis. 2014.

    Impact:

    • Considered by Ontario Public Drug Program to inform the listing of these agents

    Additional Resources:

    Funding:

    Ontario Drug Policy Research Network (ODPRN), Ontario Ministry of Health and Long-Term Care (OMHLTC)

     

    Category :

    Date : 29 Mar 2016